Akademisyen

EMRE BİLGİN

DOÇENT

SAKARYA ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ

Ana Dal Sağlık Bilimleri Temel Alanı
Yan Dal Romatoloji

Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.

Makale 44
Proje 0
Kitap 0
Bildiri 0
Patent 0
Sanatsal 0

Scopus (SJR) Q1 14 Q2 16 Q3 7 Q4 2

WoS (JCR) Q1 10 Q2 10 Q3 12 Q4 5

TR Index 7 makale

Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.

Üst %1 makale 0

Üst %10 makale 4

Ort. yüzdelik 66.1%

Üst %1 payı 0.0%

Üst %10 payı 9.8%

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Makale listesi

2025 The Risk of Developing Ocular Involvement Among Behçet’s Disease Patients Presenting with Mucocutaneous Involvement at Disease Onset: Data from the International AIDA Network Behçet’s Disease Registry Ophthalmology and Therapy DOI 10.1007/s40123-025-01258-0 YÖKSİS SJR Q1 JCR Q1 OpenAlex 85.7%
2025 ACPA is a main risk factor for CT-proven pulmonary nodule progression in patients with rheumatoid arthritis Clinical Rheumatology DOI 10.1007/s10067-025-07344-9 YÖKSİS SJR Q2 JCR Q3 OpenAlex 77.0%
2025 Behçets disease beyond the criteria: insights from a tertiary centre in Turkey Clinical and Experimental Rheumatology DOI 10.55563/clinexprheumatol/h8mxc6 YÖKSİS SJR Q2 JCR Q2 OpenAlex 76.0%
2025 QuantiFERON-TB Gold Plus for screening and monitoring latent tuberculosis infection in spondyloarthritis patients The Journal of Infection in Developing Countries DOI 10.3855/jidc.21027 YÖKSİS SJR Q3 JCR Q4 OpenAlex 80.6%
2025 From Conventional to Advanced Therapies: A National Health Registry Report (2016-2022) on DMARDs in Rheumatoid Arthritis Treatment in Turkey Biologics: Targets and Therapy DOI 10.2147/BTT.S507132 YÖKSİS SJR Q1 JCR Q2 OpenAlex 71.8%
2025 Educational and skill development needs of early-career rheumatologists in Türkiye Ulusal Romatoloji Dergisi DOI 10.4274/raed.galenos.2025.97269 YÖKSİS TR Index SJR Q4 OpenAlex 77.2%
2024 Unveiling cancer risk in ANCA-associated vasculitis: result from the Turkish Vasculitis Study Group (TRVaS) Internal and Emergency Medicine DOI 10.1007/s11739-024-03577-9 YÖKSİS SJR Q1 JCR Q1 OpenAlex 80.4%
2023 The predictors of paradoxical reactions, especially psoriasis, to biologic therapy—findings from the TReasure database: a 5-year follow-up study RHEUMATOLOGY DOI 10.1093/rheumatology/kead318 YÖKSİS SJR Q1 JCR Q1 OpenAlex 76.1%
2023 Factors that predict development of chronic kidney disease in patients with rheumatoid arthritis receiving biologic DMARDs and mortality rates International journal of rheumatic diseases DOI 10.1111/1756-185X.14967 YÖKSİS SJR Q3 JCR Q2 OpenAlex 68.7%
2023 Do the drug doses of conventional synthetic DMARDs used for the treatment of biologic/targeted-synthetic DMARDs naive rheumatoid arthritis patients affect QuantiFERON-TB Gold Plus test results? RHEUMATOLOGY INTERNATIONAL DOI 10.1007/s00296-023-05320-7 YÖKSİS SJR Q2 JCR Q2 OpenAlex 65.1%
2023 Derivation and Validation of Adult Still Activity Score (SAS) Elsevier BV DOI 10.1016/j.jbspin.2022.105499 YÖKSİS SJR Q2 JCR Q1 OpenAlex 84.1%
2023 Epidemiological characteristics of hepatitis B and C in patients with inflammatory arthritis: Implications from treasure database Archives of Rheumatology DOI 10.46497/ArchRheumatol.2023.9504 YÖKSİS TR Index SJR Q3 JCR Q4 OpenAlex 63.2%
2022 Anxiety levels before biologic initiation and changes with treatment in patients with psoriatic arthritis: HUR-BIO biologic registry results Springer Science and Business Media LLC DOI 10.1007/s10067-021-06012-y YÖKSİS SJR Q2 JCR Q3 OpenAlex 42.9%
2022 Comparison of cardiovascular, cancer and herpes zoster risk of tofacitinib versus etanercept: single-centre observational study Oxford University Press (OUP) DOI 10.1093/rheumatology/keac226 YÖKSİS SJR Q1 JCR Q1 OpenAlex 80.9%
2022 Drug retention rate and predictive factors of drug survival for secukinumab in radiographic axial spondyloarthritis Springer Science and Business Media LLC DOI 10.1007/s00296-022-05213-1 YÖKSİS SJR Q2 JCR Q2 OpenAlex 88.4%
2022 Comparison of demographic, clinic and radiological features of patients with axial spondyloarthritis accompanying familial Mediterranean fever to patients with each condition alone Informa UK Limited DOI 10.1080/03009742.2022.2143621 YÖKSİS SJR Q2 JCR Q4 OpenAlex 52.2%
2022 Differences and similarities of proliferative and non-proliferative forms of biopsy-proven lupus nephritis: Single centre, cross-disciplinary experience SAGE Publications DOI 10.1177/09612033221106305 YÖKSİS SJR Q2 JCR Q3 OpenAlex 84.5%
2022 Predicting the response to bDMARD treatment in RA: Then what? Ulusal Romatoloji Dergisi DOI 10.4274/raed.galenos.2022.69188 YÖKSİS TR Index SJR Q4 OpenAlex 13.8%
2022 Efficacy and safety of tofacitinib in rheumatoid arthritis-associated interstitial lung disease: TReasure real-life data Clinical and Experimental Rheumatology DOI 10.55563/clinexprheumatol/9h6dtb YÖKSİS SJR Q2 JCR Q3 OpenAlex 82.9%
2021 Disease characteristics of psoriatic arthritis patients may differ according to age at psoriasis onset: cross-sectional data from the Psoriatic Arthritis-International Database Clinical and Experimental Rheumatology DOI 10.55563/clinexprheumatol/ert0p7 YÖKSİS SJR Q1 JCR Q2 OpenAlex 81.8%

Akademisyenlere dön